What Pain Management Protocols Are Recommended For Ablative Co2 And Erbium:yag Laser Resurfacing? Get Expert Guidance For Optimal Comfort

For ablative CO2 and Er:YAG resurfacing, pain control should match the treatment depth, surface area, and patient factors. Localized or fractional procedures may be managed with topical anesthetic, often followed by local infiltration or regional nerve blocks. Deep, full-face resurfacing generally requires regional or infiltrative anesthesia combined with monitored systemic sedation, dissociative anesthesia, or general anesthesia in an appropriately equipped setting.

The central principle is to use the least intensive anesthetic approach that reliably controls pain for the planned treatment. Topical anesthesia may be adequate for small superficial areas, whereas extensive or deep ablation usually requires nerve blocks, tumescent or infiltrative anesthesia, and structured monitoring.

Match the Protocol to the Procedure

Small, superficial treatment areas

Topical anesthesia is generally appropriate for limited lesions or small facial zones when the planned ablation is relatively superficial. A lidocaine/prilocaine preparation or another clinician-selected topical anesthetic may be applied under occlusion for approximately 60–90 minutes, according to the product instructions and the treated area.

Topical anesthesia alone is less reliable when treating deeply, covering a large surface area, or working near highly sensitive regions. The clinician should account for total dose, contact time, occlusion, skin integrity, and the possibility of systemic absorption.

Fractional or moderate-area resurfacing

Fractional CO2 or Er:YAG resurfacing is often managed with topical anesthesia followed by local infiltration or targeted nerve blocks. Cooling, patient communication, and staged treatment can provide additional support but should not substitute for adequate anesthesia.

The appropriate approach depends on treatment density, energy settings, pulse duration, anatomic location, and patient tolerance. Er:YAG treatments may produce less residual thermal injury than CO2 treatments, but both can be painful when used at ablative depths.

Full-face or deep ablative resurfacing

Full-face ablative resurfacing generally exceeds the practical limits of topical anesthesia alone. Regional nerve blocks, local infiltration, tumescent anesthesia, and monitored systemic sedation may be combined to provide consistent analgesia.

For extensive or deeply ablative procedures, dissociative anesthesia or general anesthesia may be considered based on the patient, procedure, facility, and clinician expertise. These approaches require appropriate airway readiness, physiologic monitoring, trained personnel, and recovery capability.

Improve Injection Comfort and Coverage

Buffer local anesthetic solutions

Room-temperature local anesthetic solutions buffered with sodium bicarbonate have a higher pH and typically cause less stinging during injection. Buffering should follow an established clinical protocol because mixture stability, concentration, and storage conditions affect safe use.

Injection discomfort can also be reduced by using a small needle, injecting slowly, warming the solution appropriately, and applying topical anesthetic before infiltration when suitable.

Use regional nerve blocks strategically

Nerve blocks can anesthetize larger facial territories with fewer puncture sites and less total anesthetic volume than widespread infiltration. They are particularly useful for periorbital, perioral, forehead, cheek, and other anatomically defined treatment zones.

Blocks must be performed with accurate anatomic technique and careful dose calculation. Infiltration may still be necessary for areas not fully covered by the block or for focal regions requiring additional analgesia.

Consider tumescent or dilute infiltration anesthesia

For larger treatment areas, dilute lidocaine with epinephrine and sodium bicarbonate may provide broad analgesia while reducing bleeding. The epinephrine component may also improve visualization and procedural control when clinically appropriate.

The prolonged analgesic effect reported with tumescent techniques can reduce early post-procedure discomfort and the need for opioid medication. However, the total dose of local anesthetic must be calculated across every topical, injected, and tumescent product used.

Build the Perioperative Plan Around Safety

Screen before selecting anesthesia

The anesthetic plan should consider treatment depth, surface area, prior reactions, comorbidities, medications, pregnancy status where relevant, and the patient’s ability to remain still. The clinician should also assess active infection, impaired healing risk, and factors associated with hypertrophic scarring or post-inflammatory hyperpigmentation.

Recent isotretinoin exposure and active bacterial or viral infection may affect whether treatment should proceed. These issues require individualized clinical assessment rather than an automatic anesthetic choice.

Monitor systemic anesthesia appropriately

Sedation, dissociative anesthesia, and general anesthesia carry risks beyond pain control. They require pre-procedure assessment, continuous monitoring appropriate to the level of sedation, emergency equipment, trained staff, and documented recovery criteria.

A patient undergoing extensive resurfacing should not receive systemic anesthesia in a setting that cannot manage airway or cardiovascular complications. Facility standards and local regulations also determine which techniques are appropriate.

Prevent herpes simplex reactivation

Ablative resurfacing can reactivate herpes simplex virus, including in patients without a recent visible lesion. Perioperative antiviral prophylaxis, commonly with an agent such as acyclovir or another clinician-selected antiviral, is often used according to patient risk and local protocol.

Antiviral therapy is separate from analgesia, but it is an important part of the overall perioperative plan because painful herpetic infection can significantly complicate recovery.

Control Pain After the Procedure

Maintain a moist protective wound environment

After full-face ablation, non-adherent occlusive dressings or a clinician-selected open or closed wound-care technique can protect the exposed skin and reduce discomfort. Gentle cleansing and frequent application of a prescribed emollient barrier ointment help prevent desiccation while re-epithelialization occurs.

For extensive resurfacing, barrier recovery commonly continues for roughly 10 days, although healing time varies with depth, device settings, patient factors, and complications. Patients should not remove crusts prematurely or use irritating products on untreated skin.

Use multimodal analgesia

Post-procedure pain is usually managed with scheduled or as-needed non-opioid analgesics when medically appropriate, together with cooling measures and wound care. The exact medication plan should account for contraindications such as renal disease, gastrointestinal bleeding risk, anticoagulant use, liver disease, or drug interactions.

Opioids are not automatically required and should not be the default for every patient. If prescribed, they should be limited to the shortest clinically appropriate duration with clear instructions about sedation and other risks.

Distinguish pain from complications

Increasing pain after an initial improvement, especially with spreading redness, purulent drainage, fever, grouped vesicles, or worsening swelling, may indicate infection or another complication rather than routine recovery. Such symptoms require prompt clinical review.

Pain assessment should therefore continue after discharge. Written instructions, access to the treating team, and standardized follow-up are part of effective pain management.

Understanding the Trade-offs

Topical anesthesia has dose and absorption limits

Occlusion improves topical penetration but also increases systemic absorption. Applying topical anesthetic over large, ablated, inflamed, or damaged areas can create toxicity risk, particularly when multiple anesthetic products are combined.

Product concentration, application time, maximum dose, patient age, body size, and skin integrity must all be considered. Clinicians should follow product labeling and accepted local anesthetic safety guidance rather than treating occlusion time as a universal prescription.

More anesthesia increases monitoring requirements

Nerve blocks and infiltration reduce procedural pain without necessarily requiring deep sedation. Conversely, systemic sedation or general anesthesia may improve immobility and comfort during extensive resurfacing but increases airway, cardiovascular, recovery, and staffing requirements.

The choice should reflect the treatment plan and facility capability, not simply patient preference or a desire to eliminate all procedural sensation.

CO2 and Er:YAG are not interchangeable

CO2 systems generally create more thermal coagulation, while Er:YAG systems provide more precise ablation with less residual thermal damage. These differences can influence discomfort, bleeding, swelling, and healing, but they do not establish a single pain protocol for every device or setting.

Treatment parameters matter as much as the laser label. Pulse energy, density, number of passes, coverage, and anatomic location should be documented when planning analgesia.

Antibiotics are not analgesics

Post-procedure antibiotics are sometimes used, particularly for extensive resurfacing or according to institutional protocols, but they do not replace antiviral prophylaxis, wound care, or pain treatment. Routine antibiotic use should be based on the clinician’s assessment and antimicrobial stewardship principles.

How to Apply This to Your Procedure

The following framework should be individualized by a qualified laser clinician or anesthesia professional:

If your primary focus is a small superficial lesion: Use appropriately dosed topical anesthesia, with local infiltration or a targeted block if topical treatment does not provide adequate comfort.
If your primary focus is fractional or moderate-area resurfacing: Combine topical anesthesia with cooling, patient monitoring, and local infiltration or regional blocks based on treatment depth and density.
If your primary focus is deep or full-face ablation: Plan regional blocks, infiltrative or tumescent anesthesia, and appropriately monitored systemic sedation or anesthesia rather than relying on topical anesthetic alone.
If your primary focus is minimizing injection pain: Use room-temperature, properly buffered solutions and consider nerve blocks to reduce puncture sites and total injected volume.
If your primary focus is recovery comfort: Combine multimodal non-opioid analgesia with moist protective wound care, antiviral prophylaxis when indicated, and clear follow-up instructions.

The safest protocol is the one that matches anesthetic intensity to ablation depth and area while preserving dose control, monitoring, and reliable postoperative support.

Summary Table:

Procedure Type	Anesthesia Approach	Key Considerations
Small, superficial areas	Topical anesthesia	Apply for 60-90 minutes; monitor total dose.
Fractional or moderate-area	Topical + local infiltration or nerve blocks	Adjust based on treatment density and patient tolerance.
Full-face or deep ablation	Regional blocks, tumescent anesthesia, sedation/GA	Requires monitoring, airway readiness, and recovery support.

Contact BELIS today to learn how our advanced laser systems and comprehensive aesthetic technology can optimize your resurfacing procedures. Our expert team provides tailored solutions for clinics and premium salons, ensuring safety, efficacy, and patient satisfaction. Get in touch with us to elevate your practice!